Skip to main content
Article thumbnail
Location of Repository

Proliferation of the Superficial Epithelium of Ovaries in Senile Female Rats Following Oral Administration of Conjugated Equine Estrogens

By Sergio Eduardo Perniconi, Manuel de Jesus Simões, Ricardo dos Santos Simões, Mauro Abi Haidar, Edmund C Baracat and Jose Maria Soares
Topics: Basic Research
Publisher: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2006). A critique of Women’s Health Initiative Studies. Nucl Recept Signal.
  2. A meta-analysis of estrogen replacement therapy and risk of epithelial ovarian cancer.
  3. (1973). A study of experimental ovarian tumors in rats by chemical carcinogen, 20-methylcholanthrene. Kurume Med
  4. (1976). Capacity of old versus young female rats to secrete LH, FSH and prolactin. Biol Reprod.
  5. Cardiovascular disease outcomesduring 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
  6. Changes in ontogenetic expression of estrogen receptor alpha and not of estrogen receptor beta in the female rat reproductive tract.
  7. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer roup.
  8. Characterization of a carcinogenesis rat model of ovarian preneoplasia and neoplasia. Cancer Res.
  9. Chemical induction of ovarian tumors in rats.
  10. Cumulative exposure to high estradiol levels during the follicular phase of IVF cycles negatively affects implantation.
  11. Determinants of ovarian cancer risk. II.Inferences regarding pathogenesis.
  12. Effect of conjugated equine estrogens and tamoxifen administration on thyroid gland histomorphology of the rat.
  13. (1991). Endocrine factors in common epithelial ovarian cancer. Endocr Rev.
  14. (1996). Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol.
  15. Epithelial ovarian cancer.
  16. (2001). Estradiol regulates gonadotropin-releasing hormone (GnRH) and its receptor gene expression and antagonizes the growth inhibitory effects of GnRH in human ovarian surface epithelial and ovarian cancer cells. Endocrinology
  17. (2006). Estrogen effects on the vaginal pH, flora and cytology in late postmenopause after a long period without hormone therapy. Clin Exp Obstet Gynecol.
  18. Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells.
  19. Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen. Endocr Relat Cancer.
  20. (1998). Estrogen regulation of transforming growth factor-alpha in ovarian cancer.
  21. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.
  22. Estrogen replacement therapy and ovarian cancer.
  23. Estrogen stimulation of ovarian surface epithelial cell proliferation
  24. Estrogen stimulation of ovarian surface epithelial cell proliferation.
  25. Estrogen-progestogen replacement therapy and ovarian cancer: an update.
  26. Estrogen, progesterone and epithelial ovarian cancer.
  27. (2001). Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells. Cancer Res.
  28. Gonadotropins upregulate the epidermal growth factor receptor through activation of mitogen-activated rotein kinases and phosphatidyl-inositol-3-kinase in human ovarian surface epithelial cells. Endocr Relat Cancer.
  29. (2002). health initiative investigators),
  30. (1999). Hepatocyte growth factor induces rat ovarian surface epithelial cell mitosis or apoptosis depending on the presence or absence of an extracellular matrix. Endocrinology.
  31. (1998). Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone.
  32. (1998). Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis. Obstet Gynecol.
  33. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women.
  34. Hormone therapy in epithelial ovarian cancer. Endocr Relat Cancer.
  35. Human ovarian surface epithelial (OSE) cells express LH/hCG receptors, and hCG inhibits apoptosis of OSE cells via up-regulation of insulin-like growth factor-1.Int
  36. In vivo and in vitro studies of experimental ovarian adenocarcinoma in rats.
  37. (1998). Induction of epithelial neoplasms in the ovaries of guinea pigs by estrogenic stimulation. Gynecol Oncol.
  38. (2004). Is estrogen therapy of significance for the incidence of breast cancer? Tidsskr Nor Laegeforen.
  39. Kirk EA.Steroid hormonal regulation of proliferative, p53 tumor suppressor, and apoptotic responses of sheep ovarian surface epithelial cells.Mol Cell Endocrinol.
  40. Labrie F.Localization of oestrogen receptor alpha, oestrogen receptor beta and androgen receptors in the rat reproductive organs.J Endocrinol.
  41. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
  42. Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis. Hum Reprod Update.
  43. Neuroendocrine status of old constant-estrous rats.Neuroendocrinology.
  44. Proliferation of rhesus ovarian surface epithelial cells in culture: lack of mitogenic response to steroid or gonadotropic hormones.Endocrinology.
  45. Recurrent ovarian cancer. Clin Adv Hematol Oncol.
  46. Relationship between postmenopausal hormone replacement therapy and ovarian cancer.
  47. Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells.
  48. (1999). Review: gonadotropins and development of ovarian cancer. Oncology
  49. Rising follicle-stimulating hormone levels with age accelerate female reproductive failure.
  50. Steroid hormonal regulation of proliferative, p53 tumor suppressor, and apoptotic responses of sheep ovarian surface epithelial cells. Mol Cell Endocrinol.
  51. (2003). Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells. Mol Endocrinol.
  52. The effects of soy extract on the uterus of castrated adult rats.
  53. (1994). Transcriptional activation of c-myc proto-oncogene by estrogen in human ovarian cancer cells. Mol Cell Endocrinol.
  54. Women’s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women’s Health Initiative Randomised Controlled Trial.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.